{"schema_version":"1","generated_at":"2026-11-18T20:28:33.589Z","data_as_of":null,"url":"https://www.findmykol.com/kol/eva-galvan","json_url":"https://www.findmykol.com/kol/eva-galvan/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"eva-galvan","name":"Eva Galvan","credential":"MD","specialty":"Radiation Oncology","specialty_raw":"Radiation Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"The University of Texas at San Antonio Health Science Center","institution_url":"https://www.findmykol.com/institution/the-university-of-texas-at-san-antonio-health-science-center","city":"San Antonio","state":"TX","region":{"label":"South Central","url":"https://www.findmykol.com/region/south-central"}},"identifiers":{"npi":"1275910390","orcid":"0000-0002-6104-2605","openalex":"A5066458124"},"summary":"Eva Galvan is an Oncology physician affiliated with The University of Texas at San Antonio Health Science Center. OpenAlex indexes 25 publications with 303 citations (h-index 5); ClinicalTrials.gov lists 1 registered study matched to this name.","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":25,"cited_by_count":303,"h_index":5,"latest_activity_year":2026,"emerging":true,"source":"works"},"trials":{"count":1,"shown":2,"withheld":0,"matched_by":"investigator name, confirmed against institution and geography","rows":[{"nct":"NCT07470606","title":"Memantine +/- Raloxifene for Cognitive Preservation After Radiation Therapy to the Brain","phase":"PHASE2","status":"RECRUITING","role":"Overall official","sponsor":"The University of Texas Health Science Center at San Antonio","source_url":"https://clinicaltrials.gov/study/NCT07470606","trial_url":"https://www.findmykol.com/trial/NCT07470606"},{"nct":"NCT03799523","title":"Demonstration of a Novel Approach Using Surface-Image Guidance to Improve Delivery of Breast Radiotherapy","phase":"NA","status":"COMPLETED","role":"Overall official","sponsor":"The University of Texas Health Science Center at San Antonio","source_url":"https://clinicaltrials.gov/study/NCT03799523","trial_url":"https://www.findmykol.com/trial/NCT03799523"}],"source":"trials"},"payments":{"company_count":5,"program_years":{"first":2021,"last":null},"rows_total":7,"shown":3,"withheld":4,"rows":[{"payer":"Novocure Inc.","program_year":2025,"amount_usd":131.83,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275910390"},{"payer":"RefleXion Medical, Inc.","program_year":2024,"amount_usd":156,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275910390"},{"payer":"AstraZeneca Pharmaceuticals LP","program_year":2024,"amount_usd":101.48,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1275910390"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1275910390","source":"payments"},"prescribing":{"data_year":2024,"areas_total":3,"areas_shown":3,"areas":[{"area":"Nervous system","share_pct":40.5,"classes_total":1,"classes":[{"class":"N-methyl-D-aspartate Receptor Antagonist","setting":"prescribed","share_pct":40.5,"drugs":[{"name":"Memantine Hcl","share_pct":100}],"max_beneficiaries":null}]},{"area":"Metabolism & gastrointestinal","share_pct":33.3,"classes_total":1,"classes":[{"class":"Proton pump inhibitor","setting":"prescribed","share_pct":33.3,"drugs":[{"name":"Pantoprazole Sodium","share_pct":100}],"max_beneficiaries":null}]},{"area":"Sensory organs","share_pct":26.2,"classes_total":1,"classes":[{"class":"Corticosteroid","setting":"prescribed","share_pct":26.2,"drugs":[{"name":"Dexamethasone","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":100,"facility_pct":0},"source":"medicare"},"publications":{"total":25,"shown":5,"withheld":20,"matched_by":"OpenAlex author record","recent":[{"title":"Rapid commissioning of Brainlab Elements for SRS: end-to-end evaluation of Monte Carlo and pencil beam algorithm across homogeneous and heterogeneous phantom environments","year":2026,"journal":"Frontiers in Oncology","source_url":"https://doi.org/10.3389/fonc.2026.1893085","status":"verified"},{"title":"CLTR-06 RESPECT-LM: PHARMACOKINETIC AND PHARMACODYNAMIC ASSESSMENT OF RHENIUM OBISBEMEDA IN LEPTOMENINGEAL METASTASES WITH EMERGING DATA FROM REPEATED DOSING (RESPECT-LMM)","year":2026,"journal":"Neuro-Oncology Advances","source_url":"https://doi.org/10.1093/noajnl/vdag161.015","status":"verified"},{"title":"Sociodemographic Barriers to Successful Implementation of Optune in Glioblastoma Multiforme Patients","year":2025,"journal":"American Journal of Clinical Oncology","source_url":"https://doi.org/10.1097/coc.0000000000001188","status":"verified"},{"title":"Ferroptosis and Radiotherapy in Lung Cancer","year":2025,"journal":"Cells","source_url":"https://doi.org/10.3390/cells14231927","status":"verified"},{"title":"CTNI-67. PHASE 1 MULTICENTER STUDY OF MULTIPLE DOSES OF RHENIUM (186RE) OBISBEMEDA (REYOBIQ) FOR LEPTOMENINGEAL METASTASES: RATIONALE, DESIGN, AND PRELIMINARY COHORT 1 DATA","year":2025,"journal":"Neuro-Oncology","source_url":"https://doi.org/10.1093/neuonc/noaf201.0563","status":"verified"}],"source":"works"},"contact":{"address_1":"7979 WURZBACH RD FL 2","city":"San Antonio","state":"TX","zip":"782294427","phone":"210-450-6490","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1275910390","source":"identity"},"similar":[{"name":"Stephen E. Harris","slug":"stephen-harris","institution":"The University of Texas at San Antonio Health Science Center","url":"https://www.findmykol.com/kol/stephen-harris","json_url":"https://www.findmykol.com/kol/stephen-harris/profile.json"},{"name":"Richard Tuli","slug":"richard-tuli","institution":"The University of Texas at San Antonio Health Science Center","specialty":"Radiation Oncology","url":"https://www.findmykol.com/kol/richard-tuli","json_url":"https://www.findmykol.com/kol/richard-tuli/profile.json"},{"name":"Dean Kellogg","slug":"dean-kellogg","institution":"The University of Texas at San Antonio Health Science Center","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/dean-kellogg","json_url":"https://www.findmykol.com/kol/dean-kellogg/profile.json"},{"name":"Marcos Restrepo","slug":"marcos-restrepo","institution":"The University of Texas at San Antonio Health Science Center","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/marcos-restrepo","json_url":"https://www.findmykol.com/kol/marcos-restrepo/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":4,"publications":20}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-04-08","provider_certified":"2021-04-08","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"trials":{"name":"ClinicalTrials.gov","url":"https://clinicaltrials.gov","provides":"Investigator roles on registered clinical studies"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}